manufacturers of glp 1 drugs GLP-1 trend to impact food Compounded GLP-1 Drugs and its

A special thanks to the head of the metabolic kitchen at my old department (now Department of Nutrition, Exercise and Sports), Charlotte Kostecki, for her invaluable creativity and support, and to my former PA Tina Cuthbertson for making it possible to be head of the department and still conducting research

Common GLP-1 drugs include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) These drugs improve insulin resistance , aid in weight loss , and now appear to reduce inflammation , offering benefits far beyond diabetes

Their idea was backed up by the findings of Unger and other researchers like Keith Buchanan, a Scottish specialist in metabolic medicine at Queens University in Belfast, Northern Ireland (Marks 2018

Suppresses Appetite: Reduces food cravings and helps control calorie intake through natural appetite suppression

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as monotherapy or add-on to metformin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis